Ayurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million.
Ayurcann is an award-winning Canadian cannabis extraction company that specializes in the processing and manufacturing of cannabis 2.0 and 3.0 products:
Miami, FL and Toronto, Canada, June 27, 2024 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (“Ayurcann” or the “Company”) (CSE: AYUR; OTCQB:AYURF; FSE: 3ZQ0), an award winning Canadian cannabis extraction company specializing in the processing and manufacturing of pharma grade cannabis and hemp for various derivative cannabis products, and Arogo Capital Acquisition Corporation (“Arogo”) (NASDAQ:AOGOU, AOGO, AOGOW), a special purpose acquisition company, announced today that they have entered into a definitive business combination agreement dated June 26, 2024 (the “Business Combination Agreement”, and the transactions contemplated therein, the “Transaction”). The Business Combination is an arm’s length agreement. In connection with the Transaction, ARC Group Limited will receive finder’s fees in the amount of 799,731 common shares of the Company.
Related news for (AYURF)
- AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE
- AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE
- Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs
- AYURCANN ANNOUNCES AGSM RESULTS